buy

EyePoint Pharmaceuticals Inc. buy JPMorgan Chase & Co.

EyePoint Pharmaceuticals Inc.

Start price

€7.68

/ 50%

Target price

13.08.25

Performance (%)

Price

Summary

This prediction is currently active. The BUY prediction by JPMorgan_Chase___Co_ is currently unchanged from the start price. This prediction currently runs until 13.08.25. The prediction end date can be changed by JPMorgan_Chase___Co_ at any time. JPMorgan_Chase___Co_ has 50% into this prediction

Performance without dividends (%)

Name	1w
EyePoint Pharmaceuticals Inc.
iShares Core DAX®
iShares Nasdaq 100
iShares Nikkei 225®
iShares S&P 500

Comments by JPMorgan_Chase___Co_ for this prediction

In the thread EyePoint Pharmaceuticals Inc. diskutieren

Prediction Buy

Perf. (%)

Target price 26.500

Change

Ends at

EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT) had its price target lowered by analysts at JPMorgan Chase & Co. from $32.00 to $29.00. They now have an "overweight" rating on the stock.

Ratings data for EYPT provided by MarketBeat

JPMorgan Chase & Co.